Skip to main content
Erschienen in: Annals of Surgical Oncology 8/2018

24.05.2018 | Bone and Soft Tissue Sarcomas

Long-Term Outcome After Surgery for a Localized Retroperitoneal Soft Tissue Sarcoma in Elderly Patients: Results from a Retrospective, Single-Center Study

verfasst von: I. Sourrouille, MD, R. Macovei, MD, M. Faron, MD, C. Le Péchoux, MD, O. Mir, MD, PhD, J. Adam, MD, PhD, S. Dumont, MD, PhD, P. Terrier, MD, A. Le Cesne, MD, C. Honoré, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 8/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

To evaluate short- and long-term results after curative surgery for a retroperitoneal sarcoma (RPS) in elderly patients.

Methods

We retrospectively analyzed data of all patients operated in our single, tertiary care center for a nonmetastatic RPS and identified patients aged 70 years and older.

Results

Among 296 patients with an RPS treated between 1994 and 2015, 60 (20%) were aged 70 years and older (median age 74 years; range 70–85). The median tumor size was 24 cm (range 6–46). Forty-six patients (77%) had mass-related symptoms at the time of diagnosis. The most frequent histological subtypes were de-differentiated liposarcoma (53%, n = 32) and well-differentiated liposarcoma (35%, n = 21). Twenty-two patients (37%) had perioperative radiotherapy and/or chemotherapy. Fifty-eight patients (97%) had macroscopically complete resection. The postoperative mortality was 8% and severe morbidity (Dindo/Clavien ≥ 3) was 32%. A reoperation was required for ten patients (17%). After a median follow-up of 20 months (range 1–121), the 5-year overall survival (OS) rate was 90% (95% confidence interval [CI] 79–100%), and median OS was not reached. The cancer-specific death rate was 88%. No prognostic factor for disease-specific survival was detected. The 5-year disease-free survival (DFS) rate was 52% (95% CI 33–84%) and 5-year locoregional recurrence-free survival rate was 52% (95% CI 33–84%). Median DFS was 94 months (95% CI 35–NA). Reoperation after inappropriate surgery and postoperative morbidity were independent predictive factors of locoregional relapse. No predictive factors of distant metastasis were found.

Conclusions

Curative surgery is feasible in selected elderly patients but with higher mortality and morbidity rates than in younger patients. It enables a prolonged survival. Future studies should focus on selection process to minimize postoperative mortality and morbidity.
Literatur
1.
Zurück zum Zitat La situation du cancer en France en 2010 collection rapport et synthèses. Ouvrage collectif édité par l’INCa, Boulogne-Bilancourt. 2010;193–195. Available at www.e-cancer.fr on 05/01/2016 [in French]. La situation du cancer en France en 2010 collection rapport et synthèses. Ouvrage collectif édité par l’INCa, Boulogne-Bilancourt. 2010;193–195. Available at www.​e-cancer.​fr on 05/01/2016 [in French].
2.
Zurück zum Zitat Ducimitiere F, Lurkin A, Ranchere-Vince D, et al. Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing. PLoS One. 2011;6:e20294.CrossRef Ducimitiere F, Lurkin A, Ranchere-Vince D, et al. Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing. PLoS One. 2011;6:e20294.CrossRef
3.
Zurück zum Zitat ESMO/European Sarcoma Network Working Group. Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25:iii102–112. ESMO/European Sarcoma Network Working Group. Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25:iii102–112.
4.
Zurück zum Zitat Gronchi A, Strauss DC, Miceli R, et al. Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group. Ann Surg. 2016;263:1002–9.CrossRefPubMed Gronchi A, Strauss DC, Miceli R, et al. Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group. Ann Surg. 2016;263:1002–9.CrossRefPubMed
5.
Zurück zum Zitat Bonvalot S, Raut CP, Pollock RE, et al. Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-surge, a master class in sarcoma surgery, and EORTC-STBSG. Ann Surg Oncol. 2012;19:2981–91.CrossRefPubMed Bonvalot S, Raut CP, Pollock RE, et al. Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-surge, a master class in sarcoma surgery, and EORTC-STBSG. Ann Surg Oncol. 2012;19:2981–91.CrossRefPubMed
6.
Zurück zum Zitat Dindo D, Demartines N, Clavien P. Classification of surgical complications: a new proposal with evaluation in a cohort pf 6336 patients and results of a surgery. Ann Surg. 2004;240:205–13.CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien P. Classification of surgical complications: a new proposal with evaluation in a cohort pf 6336 patients and results of a surgery. Ann Surg. 2004;240:205–13.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Sobin LH, Wittekind C. Tumours of bone and soft tissues. TNM classification of malignant tumours. New York: Wiley-Liss; 2002. Sobin LH, Wittekind C. Tumours of bone and soft tissues. TNM classification of malignant tumours. New York: Wiley-Liss; 2002.
8.
Zurück zum Zitat Gronchi A, Miceli R, Shurell E, et al. Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets. J Clin Oncol. 2013;31:1649–55.CrossRefPubMed Gronchi A, Miceli R, Shurell E, et al. Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets. J Clin Oncol. 2013;31:1649–55.CrossRefPubMed
9.
Zurück zum Zitat Rusell WO, Cohen J, Enzinger F, et al. A clinical and pathological staging system for soft tissue sarcomas. Cancer. 1977;40:1562–70.CrossRef Rusell WO, Cohen J, Enzinger F, et al. A clinical and pathological staging system for soft tissue sarcomas. Cancer. 1977;40:1562–70.CrossRef
10.
Zurück zum Zitat Trojani M, Contesso G, Coindre JM, et al. Soft tissue sarcomas of adults; study of pathological prognosis variables and definition of a histopathological grading system. Int J Cancer. 1984; 33:37–42.CrossRefPubMed Trojani M, Contesso G, Coindre JM, et al. Soft tissue sarcomas of adults; study of pathological prognosis variables and definition of a histopathological grading system. Int J Cancer. 1984; 33:37–42.CrossRefPubMed
14.
Zurück zum Zitat Honoré C, Méeus P, Stoeckle E, Bonvalot S. Soft tissue sarcoma in France in 2015: Epidemiology, classification and organization of clinical care. J Visc Surg. 2015;152:223–30.CrossRefPubMed Honoré C, Méeus P, Stoeckle E, Bonvalot S. Soft tissue sarcoma in France in 2015: Epidemiology, classification and organization of clinical care. J Visc Surg. 2015;152:223–30.CrossRefPubMed
16.
Zurück zum Zitat Brighi N, Balducci L, Biasco G. Cancer in the elderly: is it time for palliative care in geriatric oncology? J Geriatr Oncol. 2014;5:197–203.CrossRefPubMed Brighi N, Balducci L, Biasco G. Cancer in the elderly: is it time for palliative care in geriatric oncology? J Geriatr Oncol. 2014;5:197–203.CrossRefPubMed
17.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373–83.CrossRefPubMed Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373–83.CrossRefPubMed
19.
Zurück zum Zitat Hurria A. Embracing the complexity of comorbidity. J Clin Oncol. 2011;32:4217–18.CrossRef Hurria A. Embracing the complexity of comorbidity. J Clin Oncol. 2011;32:4217–18.CrossRef
20.
Zurück zum Zitat Extermann M, Boler I, Reich RR, et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer. 2012;13:3377–86.CrossRef Extermann M, Boler I, Reich RR, et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer. 2012;13:3377–86.CrossRef
21.
Zurück zum Zitat Extermann M, Overcash J, Lyman GH, et al. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol. 1998;16:1582–7.CrossRefPubMed Extermann M, Overcash J, Lyman GH, et al. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol. 1998;16:1582–7.CrossRefPubMed
22.
Zurück zum Zitat Repetto L, Fratino L, Audisio RA, et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol. 2002;20:494–502.CrossRefPubMed Repetto L, Fratino L, Audisio RA, et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol. 2002;20:494–502.CrossRefPubMed
23.
Zurück zum Zitat Pamoukdjian F, Paillaud E, Zelek L et al. Measurement of gait speed in older adults to identify complications associated with frailty: a systematic review. J Geriatric Oncol. 2015;6:484–96.CrossRef Pamoukdjian F, Paillaud E, Zelek L et al. Measurement of gait speed in older adults to identify complications associated with frailty: a systematic review. J Geriatric Oncol. 2015;6:484–96.CrossRef
24.
Zurück zum Zitat Bonvalot S, Miceli R, Berselli M et al. Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control. Ann Surg Oncol. 2010;17(6):1507–14.CrossRefPubMed Bonvalot S, Miceli R, Berselli M et al. Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control. Ann Surg Oncol. 2010;17(6):1507–14.CrossRefPubMed
25.
Zurück zum Zitat Lahat G, Dhuka AR, Lahat S et al. Complete soft tissue sarcoma resection is a viable treatment option for select elderly patients. Ann Surg Oncol. 2009;9:2579–86.CrossRef Lahat G, Dhuka AR, Lahat S et al. Complete soft tissue sarcoma resection is a viable treatment option for select elderly patients. Ann Surg Oncol. 2009;9:2579–86.CrossRef
26.
Zurück zum Zitat Landi F, Vallribera F, Rivera JP, et al. Morbidity after laparoscopic and open rectal cancer surgery: a comparative analysis of morbidity in octogenarians and younger patients. Colorectal Dis. 2016;5:459–67.CrossRef Landi F, Vallribera F, Rivera JP, et al. Morbidity after laparoscopic and open rectal cancer surgery: a comparative analysis of morbidity in octogenarians and younger patients. Colorectal Dis. 2016;5:459–67.CrossRef
27.
Zurück zum Zitat Kim DB, Gray R, Li Z, et al. Effect of nephrectomy for retroperitoneal sarcoma on post-operative renal function. J Surg Oncol. 2017 Oct 16. [Epub ahead of print]. Kim DB, Gray R, Li Z, et al. Effect of nephrectomy for retroperitoneal sarcoma on post-operative renal function. J Surg Oncol. 2017 Oct 16. [Epub ahead of print].
28.
Zurück zum Zitat Cho CW, Lee KW, Park H, et al. Clinical benefit and residual kidney function of en bloc nephrectomy for perirenal retroperitoneal sarcoma. Asia-Pac J Clin Oncol. 2017;1–7. Cho CW, Lee KW, Park H, et al. Clinical benefit and residual kidney function of en bloc nephrectomy for perirenal retroperitoneal sarcoma. Asia-Pac J Clin Oncol. 2017;1–7.
29.
Zurück zum Zitat Mir O, Domont J, Cioffi A, et al. Feasibility of metronomic oral cyclophosphamide plus prednisolone in elderly patients with inoperable or metastatic soft tissue sarcoma. Eur J Cancer. 2011;4:515–9.CrossRef Mir O, Domont J, Cioffi A, et al. Feasibility of metronomic oral cyclophosphamide plus prednisolone in elderly patients with inoperable or metastatic soft tissue sarcoma. Eur J Cancer. 2011;4:515–9.CrossRef
30.
Zurück zum Zitat O’Connell JB, Maggard MA, Ko CY. Cancer-directed surgery for localized disease: decreased use in the elderly. Ann Surg Oncol. 2004;11:962–9.CrossRefPubMed O’Connell JB, Maggard MA, Ko CY. Cancer-directed surgery for localized disease: decreased use in the elderly. Ann Surg Oncol. 2004;11:962–9.CrossRefPubMed
31.
Zurück zum Zitat Desbat NH, Levy A, Auberdiac P, et al. Curative-intended treatment of squamous cell anal carcinoma in elderly adults. J Am Geriatr Soc. 2012;60:1993–4.CrossRefPubMed Desbat NH, Levy A, Auberdiac P, et al. Curative-intended treatment of squamous cell anal carcinoma in elderly adults. J Am Geriatr Soc. 2012;60:1993–4.CrossRefPubMed
33.
Zurück zum Zitat Judson I, Verweij J, Gelderblom H, et al. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. European Organisation and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Lancet Oncol. 2014;4:415–23.CrossRef Judson I, Verweij J, Gelderblom H, et al. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. European Organisation and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Lancet Oncol. 2014;4:415–23.CrossRef
34.
Zurück zum Zitat Jensen SA, Vilmar A, Sørensen JB. Adjuvant chemotherapy in elderly patients (≥ 75 year) completely resected for colon cancer stage III compared to younger patients. Med Oncol. 2006;4:512–31. Jensen SA, Vilmar A, Sørensen JB. Adjuvant chemotherapy in elderly patients (≥ 75 year) completely resected for colon cancer stage III compared to younger patients. Med Oncol. 2006;4:512–31.
35.
Zurück zum Zitat Serizawa I, Kagei K, Kamada T, et al. Carbon ion radiotherapy for unresectable retroperitoneal sarcomas. Int J Radiat Oncol Biol Phys. 2009;75:1105–10.CrossRefPubMed Serizawa I, Kagei K, Kamada T, et al. Carbon ion radiotherapy for unresectable retroperitoneal sarcomas. Int J Radiat Oncol Biol Phys. 2009;75:1105–10.CrossRefPubMed
36.
Zurück zum Zitat Paumier A, Le Péchoux C, Beaudré A, et al. IMRT or conformal radiotherapy for adjuvant treatment of retroperitoneal sarcoma? Radiother Oncol. 2011;99:73–8.CrossRefPubMed Paumier A, Le Péchoux C, Beaudré A, et al. IMRT or conformal radiotherapy for adjuvant treatment of retroperitoneal sarcoma? Radiother Oncol. 2011;99:73–8.CrossRefPubMed
Metadaten
Titel
Long-Term Outcome After Surgery for a Localized Retroperitoneal Soft Tissue Sarcoma in Elderly Patients: Results from a Retrospective, Single-Center Study
verfasst von
I. Sourrouille, MD
R. Macovei, MD
M. Faron, MD
C. Le Péchoux, MD
O. Mir, MD, PhD
J. Adam, MD, PhD
S. Dumont, MD, PhD
P. Terrier, MD
A. Le Cesne, MD
C. Honoré, MD, PhD
Publikationsdatum
24.05.2018
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 8/2018
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-6529-z

Weitere Artikel der Ausgabe 8/2018

Annals of Surgical Oncology 8/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.